ERK1/2 and JNKs, but not p38 Kinase, Are Involved in Reactive Oxygen Species-Mediated Induction of Osteopontin Gene Expression by Angiotensin II and Interleukin-1β in Adult Rat Cardiac Fibroblasts

Journal of Cellular Physiology

Volumn 198, Issue 3, 2004, Pages 399-407

  Xie, Zhonglin ^a   Singh, Mahipal ^a   Singh, Krishna ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGEN; DIPHENYLIODONIUM SALT; ENZYME INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; JNK ACTIVATING PROTEIN KINASE; JNK-ACTIVATING PROTEIN KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIALOGLYCOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TIRON; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ARTICLE; CELL CULTURE; COLLAGEN SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; GENE INDUCTION; GENETICS; HEART; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; METABOLISM; NONHUMAN; NORTHERN BLOTTING; PHYSIOLOGY; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION; HEART; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOPONTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

TIRON;

EID: 1242272154     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10419     Document Type: Article

References (53)

1. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA. 1996. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 98:2218-2227.
2. Bardwell AJ, Abdollahi M, Bardwell L. 2003. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases, and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Biochem J 370:1077-1085.
3. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, Mukherjee BB. 1994. Osteopontin: Its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem (Tokyo) 115:675-682.
4. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Clerk A, Michael A, Sugden PH. 1998. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1, and phenylephrine: A role in cardiac myocyte hypertrophy? J Cell Biol 142:523-535.
6. Communal C, Colucci WS, Singh K. 2000. p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J Biol Chem 275:19395-19400.
7. Denhardt DT, Guo X. 1993. Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
8. Eghbali M, Blumenfeld OO, Seifter S, Buttrick PM, Leinwand LA, Robinson TF, Zern MA, Giambrone MA. 1989. Localization of types I, III, and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol 21:103-113.
9. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. 2000. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241-247.
10. Force T, Bonventre JV. 1998. Growth factors and mitogen-activated protein kinases. Hypertension 31:152-161.
11. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM. 1996. Stress-activated protein kinases in cardiovascular disease. Circ Res 78:947-953.
12. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. 1995. Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 760:109-126.
13. Griendling KK, Sorescu D, Ushio-Fukai M. 2000. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86:494-501.
14. Gurantz D, Cowling RT, Villarreal FJ, Greenberg BH. 1999. Tumor necrosis factor-alpha upregulates angiotensin II type I receptors on cardiac fibroblasts. Circ Res 85:272-279.
15. Gurjar MV, Deleon J, Sharma RV, Bhalla RC. 2001. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am J Physiol Heart Circ Physiol 281:H2568-H2574.
16. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108:73-81.
17. Herdegen T, Skene P, Bahr M. 1997. The c-Jun transcription factor-bipotential mediator of neuronal death, survival, and regeneration. Trends Neurosci 20:227-231.
18. Hsu HY, Wen MH. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277:22131-22139.
19. Jung YD, Liu W, Reinmuth N, Ahmad SA, Fan F, Gallick GE, Ellis LM. 2001. Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 4:155-162.
20. Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Maenpaa PH. 1999. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem 274:1729-1735.
21. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. 2001. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 24:251-261.
22. Li YY, McTiernan CF, Feldman AM. 2000. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46:214-224.
23. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. 1998. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 101:1468-1478.
24. Lo YY, Wong JM, Cruz TF. 1996. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271:15703-15707.
25. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. 1999. Chronic myocardial infarction in the mouse: Cardiac structural and functional changes. Cardiovasc Res 41:586-593.
26. MacKenna DA, Dolfi F, Vuori K, Ruoslahti E. 1998. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest 101:301-310.
27. Maziere C, Conte MA, Degonville J, Ali D, Maziere JC. 1999. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 265:116-122.
28. Mukherjee BB, Nemir M, Beninati S, Cordella-Miele E, Singh K, Chackalaparampil I, Shanmugam V, DeVouge MW, Mukherjee AB. 1995. Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann NY Acad Sci 760:201-212.
29. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. 1998. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98:149-156.
30. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ. 1999. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580.
31. Post GR, Goldstein D, Thuerauf DJ, Glembotski CC, Brown JH. 1996. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 271:8452-8457.
32. Puri PL, Avantaggiati ML, Burgio VL, Chirillo P, Collepardo D, Natoli G, Balsano C, Levrero M. 1995. Reactive oxygen intermediates mediate angiotensin II-induced c-Jun, c-Fos heterodimer DNA binding activity, and proliferative hypertrophic responses in myogenic cells. J Biol Chem 270:22129-22134.
33. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
34. Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH. 1997. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 272:14057-14061.
35. Robinson CM, Prime SS, Huntley S, Stone AM, Davies M, Eveson JW, Paterson IC. 2001. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation. Int J Cancer 91:625-630.
36. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S. 2001. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661-669.
37. Singh K, Mukherjee AB, De Vouge MW, Mukherjee BB. 1992. Differential processing of osteopontin transcripts in rat kidney- and osteoblast-derived cell lines. J Biol Chem 267:23847-23851.
38. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. 1995. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem 270:28471-28478.
39. Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, Bing OH, Colucci WS. 1999. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 33:663-670.
40. Siwik DA, Chang DL, Colucci WS. 2000. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259-1265.
41. Sugden PH, Clerk A. 1997. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9:337-351.
42. Sun Y, Weber KT. 2000. Infarct scar: A dynamic tissue. Cardiovasc Res 46:250-256.
43. Touyz RM, Schiffrin EL. 2000. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672.
44. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K. 2001. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080-1087.
45. Uede T, Katagiri Y, Iizuka J, Murakami M. 1997. Osteopontin, a coordinator of host defense system: A cytokine or an extracellular adhesive protein? Microbiol Immunol 41:641-648.
46. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. 1996. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321.
47. Weber KT, Sun Y, Tyagi SC, Cleutjens JP. 1994. Collagen network of the myocardium: Function, structural remodeling, and regulatory mechanisms. J Mol Cell Cardiol 26:279-292.
48. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
49. Xiao L, Pimental DR, Amin JK, Singh K, Sawyer DB, Colucci WS. 2001. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33:779-787.
50. Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS, Singh K. 2001a. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: Role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol 188:132-138.
51. Xie Z, Siwik DA, Colucci WS, Singh K. 2001b. Angiotensin II and interleukin-1beta synergistically increase osteopontin expression in adult rat cardiac fibroblasts: Role in regulation of matrix metalloproteinase activity. Circulation 104:II-57 (abstract).
52. Yang SH, Vickers E, Brehm A, Kouzarides T, Sharrocks AD. 2001. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol Cell Biol 21:2802-2814.
53. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC. 1997. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139:115-127.